Overview

A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer

Status:
Terminated

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

To determine the safety and efficacy of second-line treatment with Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the second line treatment of advanced colorectal cancer

Phase:

Phase 2

Details

Lead Sponsor:

Gachon University Gil Medical Center

Treatments:

Metformin